Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bellerophon Therapeutics, Inc.

0.0120
0.0000
Volume:- -
Turnover:- -
Market Cap:146.79K
PE:-0.01
High:0.0120
Open:0.0120
Low:0.0120
Close:0.0120
Loading ...
Mar 31, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 31, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 28, 2022

Major Issues Report

8-K - Current report
Jan 05, 2022

Major Issues Report

8-K - Current report
Jan 04, 2022

Major Issues Report

8-K/A [Amend] - Current report
Dec 17, 2021

Major Issues Report

8-K - Current report
Oct 08, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Jun 11, 2021

Major Issues Report

8-K/A [Amend] - Current report
Jun 11, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 26, 2021

Major Issues Report

8-K - Current report
May 11, 2021

Major Issues Report

8-K - Current report
May 11, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 28, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 31, 2021

Major Issues Report

8-K - Current report
Mar 11, 2021

Major Issues Report

8-K - Current report
Mar 11, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2021

Major Issues Report

8-K - Current report
Jan 05, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals